Patents by Inventor Soad Saleh

Soad Saleh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VCP and factor H as viral entry inhibitors
    Patent number: 11707505
    Abstract: The present invention further relates to using vaccinia virus complement control protein (VCP), factor H and/or a complement control protein (CCP)-containing protein as modulator of the entry and/or replication of pathogen(s), wherein the pathogen is a virus or bacteria. The present invention further relates to a method of prevention and/or treatment of influenza A virus (IAV) infection in a subject of need thereof and to a method of modulation of the entry and/or replication of pathogen(s) in a subject of need thereof.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: July 25, 2023
    Assignee: KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE
    Inventors: Futwan Al-Mohanna, Uday Kishore, Katharine Collison, Valarmathy Murugiah, Soad Saleh, Praveen Mathews Varghese
  • VCP AND FACTOR H AS VIRAL ENTRY INHIBITORS
    Publication number: 20210145935
    Abstract: The present invention further relates to using vaccinia virus complement control protein (VCP), factor H and/or a complement control protein (CCP)-containing protein as modulator of the entry and/or replication of pathogen(s), wherein the pathogen is a virus or bacteria. The present invention further relates to a method of prevention and/or treatment of influenza A virus (IAV) infection in a subject of need thereof and to a method of modulation of the entry and/or replication of pathogen(s) in a subject of need thereof.
    Type: Application
    Filed: November 15, 2019
    Publication date: May 20, 2021
    Inventors: FUTWAN AL-MOHANNA, UDAY KISHORE, KATHARINE COLLISON, VALARMATHY MURUGIAH, SOAD SALEH, PRAVEEN MATHEWS VARGHESE
  • TETRASPANIN CD82 AS A DIAGNOSTIC AND/OR THERAPEUTIC MODULE FOR XENOGRAFT RECOGNITION AND/OR REJECTION
    Publication number: 20160310530
    Abstract: The present invention relates to CD82 polypeptides of the mammalian tetraspanin CD82 protein family for use in the diagnosis, prevention and/or treatment of xenograft recognition and/or rejection. The present invention furthermore relates to CD82 knockout and transgenic animals and their cells, tissues and organs. The present invention furthermore relates to antibodies against a CD82 polypeptide, pharmaceutical compositions comprising at least one inhibitor of a CD82 polypeptide or comprising cells, tissues and organs of animals in which the CD82 level, expression and/or activity is modified, and their use in the diagnosis, prevention and/or treatment of xenograft recognition and/or rejection. The present invention furthermore relates to methods of diagnosing xenograft recognition and/or rejection and methods for the prevention and/or treatment of xenograft recognition and/or rejection as well as methods of xenotransplantation.
    Type: Application
    Filed: April 6, 2016
    Publication date: October 27, 2016
    Inventors: FUTWAN AL-MOHANNA, SOAD SALEH, RANJIT PARHAR, REEM AL-HEJAILAN, RAZAN BEKHEET, KATE COLLISON
  • Tetraspanin CD82 as a Diagnostic and/or Therapeutic Module for Xenograft Recognition and/or Rejection
    Publication number: 20140075585
    Abstract: The present invention relates to CD82 polypeptides of the mammalian tetraspanin CD82 protein family for use in the diagnosis, prevention and/or treatment of xenograft recognition and/or rejection. The present invention furthermore relates to CD82 knockout and transgenic animals and their cells, tissues and organs. The present invention furthermore relates to antibodies against a CD82 polypeptide, pharmaceutical compositions comprising at least one inhibitor of a CD82 polypeptide or comprising cells, tissues and organs of animals in which the CD82 level, expression and/or activity is modified, and their use in the diagnosis, prevention and/or treatment of xenograft recognition and/or rejection. The present invention furthermore relates to methods of diagnosing xenograft recognition and/or rejection and methods for the prevention and/or treatment of xenograft recognition and/or rejection as well as methods of xenotransplantation.
    Type: Application
    Filed: September 12, 2012
    Publication date: March 13, 2014
    Inventors: Futwan Al-Mohanna, Soad Saleh, Ranjit Parhar, Reem Al-Hejailan, Razan Bekheet, Kate Collison